Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05671276
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT05671276
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05671276. Randomized; single masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2024-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion
- Condition
- Atrial Fibrillation
- Condition
- Left Atrial Appendage Occlusion
- Condition
- Silent Cerebral Embolism
- Intervention (Drug)
- aspirin and clopidogrel
- Intervention (Drug)
- Rivaroxaban
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Collaborator
- Second Affiliated Hospital of Nantong University
- Collaborator
- Jiangsu Taizhou People's Hospital
Record details
- Record id
cardio:ct-nct05671276- Content hash
5d06aa7a5fb84b462ab2db6a78074f8c960e62e64f5e7fad7d3eec9bbcd04c3a